• Print

Direct health expenditure attributed to COPD in Australia was $560 million in the 2004–05 financial year, amounting to 1% of the total direct expenditure on diseases.

The greatest proportion of expenditure was due to hospital costs for admitted COPD patients.

The expenditure consisted of:

  • 60% admitted patient costs (a)
  • 26% prescription medicines (b)
  • 13% out-of-hospital costs
  • 2% research funding
Pie chart, showing COPD expenditure; hospital patients (a), prescriptions (b), medical services, research
  1. Includes public and private acute hospitals, and psychiatric hospitals. Includes medical services provided to private admitted patients in hospital.
  2. Includes all medicines for which a prescription is needed, including benefit-paid prescriptions, private prescriptions and under-copayment prescriptions. Prescription medicines include expenditure on cor pulmonale (right heart failure due to lung disease) (approx. 0.5%).

Source: AIHW disease expenditure database as at December 2008.

There is more expenditure on males than females. For example, in the 75–84 years age group $111 million was spent on males compared with $81 million on females.

COPD - expenditure by age GIF
  1. Includes public and private acute hospitals, and psychiatric hospitals. Includes medical services provided to private admitted patients in hospital.
  2. Includes all medicines for which a prescription is needed, including benefit-paid prescriptions, private prescriptions and under-copayment prescriptions. Prescription medicines include expenditure on cor pulmonale (approx. 0.5%).

Source: AIHW disease expenditure database as at December 2008.

Source tables

Table 1: Direct expenditure allocated to COPD by type of expenditure, 2004–05
$ millions Per cent
Admitted patient costs (a) 334 60%
Prescription medicines (b) 144 26%
Out-of-hospital medical services 71 13%
Research 11 2%
Total 560 100%
  1. Includes public and private acute hospitals, and psychiatric hospitals. Includes medical services provided to private admitted patients in hospital.
  2. Includes all medicines for which a prescription is needed, including benefit-paid prescriptions, private prescriptions and under-copayment prescriptions. Prescription medicines include expenditure on cor pulmonale (right heart failure due to lung disease ) (approx. 0.5%).

Source: AIHW disease expenditure database as at December 2008.

Table 2: Direct expenditure allocated to COPD, by age, sex and area of health expenditure, 2004–05, ($ millions)
Age Males Females
Admitted patients (a) Prescription medicines (b) Out-of-hospital medical services Admitted patients (a) Prescription medicines (b) Out-of-hospital medical services
0–4 0.218 0.160 0.004 0.104 0.071 0.012
5–14 0.128 0.429 0.041 0.173 0.174 0.019
15–24 0.239 0.186 0.042 0.313 0.164 0.167
25–34 0.406 0.385 0.731 0.484 0.391 0.063
35–44 1.572 1.279 1.081 2.092 1.328 1.070
45–54 7.270 5.900 2.817 10.090 4.504 2.218
55–64 24.183 15.469 10.915 26.032 12.414 6.939
65–74 53.801 27.391 12.425 42.973 16.468 9.019
75–84 73.360 25.130 12.532 51.577 21.036 8.459
85+ 20.892 5.691 1.342 17.843 5.112 1.403
Total 182.069 82.020 41.930 151.681 61.662 29.369
  1. Includes public and private acute hospitals, and psychiatric hospitals. Includes medical services provided to private admitted patients in hospital.
  2. Includes all medicines for which a prescription is needed, including benefit-paid prescriptions, private prescriptions and under-copayment prescriptions. Prescription medicines include expenditure on cor pulmonale (approx. 0.5%).

Source: AIHW disease expenditure database as at December 2008.